OPTUS Pharmaceutical Co., Ltd. Logo

OPTUS Pharmaceutical Co., Ltd.

Develops and manufactures ophthalmic solutions for dry eye, infections, and inflammation.

131030 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
충청북도 청주시 흥덕구 오송읍 오송생명6로 50, 청주시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

OPTUS Pharmaceutical Co., Ltd. (formerly DHP Korea Co Ltd) is a specialized pharmaceutical company dedicated to providing total eye care solutions. The company develops, manufactures, and markets a comprehensive portfolio of ophthalmic products targeting conditions such as dry eye syndrome, bacterial infections, and inflammation. Its product line includes preservative-free artificial tears and medicated eye drops with active ingredients like sodium hyaluronate, cyclosporine, and moxifloxacin. OPTUS Pharmaceutical operates a dedicated, GMP-compliant manufacturing plant that specializes in producing single-dose ophthalmic preparations, ensuring high standards of safety and quality. The company is committed to continuous research and innovation in eye health and also provides contract manufacturing services.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for OPTUS Pharmaceutical Co., Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 994.7 KB

Automate Your Workflow. Get a real-time feed of all OPTUS Pharmaceutical Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for OPTUS Pharmaceutical Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Pharmena S.A. Logo
Develops dietary supplements using its patented 1-MNA molecule to support healthy aging.
Poland PHR
Bulgaria PHRM
Pharmicell Co.,Ltd. Logo
Biopharma firm in stem cell therapies, biochemicals, cell banking, and stem cell cosmetics.
South Korea 005690
Pharming Group N.V. Logo
Develops & commercializes protein & precision medicines for rare, life-threatening diseases.
Netherlands PHARM
Pharmocann Global Ltd. Logo
Develops pharma-grade medical cannabis products like oils, ointments, tablets, and cosmetics.
Israel PMCN-M
Pherecydes Pharma Logo
Develops precision phage therapy to treat resistant bacterial infections.
France ALPHE
Philogen Logo
Developing targeted biopharmaceuticals for oncology using proprietary ligand-based delivery.
Italy PHIL
Photocure ASA Logo
Develops photodynamic pharmaceuticals and devices to enhance bladder cancer detection for urologists.
Norway PHO
Pierrel Logo
Global pharma company specializing in dental anesthetics and contract manufacturing services.
Italy PRL
Develops DNA vaccines and therapeutics for companion animals and livestock.
South Korea 222670

Talk to a Data Expert

Have a question? We'll get back to you promptly.